Treatment of Infarct Related Heart Failure: Vasodilators Other Than ACE Inhibitors

Overview

Journal Cardiovasc Drugs Ther

Specialties Cardiology & Vascular Diseases
Pharmacology

Date 1994 Feb 1

PMID 8086321

Authors

J N Cohn

Affiliations

Soon will be listed here.

Abstract

Vasodilator drugs, particularly intravenously infused nitroprusside and an orally administered combination of hydralazine and isosorbide dinitrate, exert a profoundly favorable hemodynamic effect in the setting of heart failure complicating a prior myocardial infarction. Although these oral drugs also may relieve symptoms and improve exercise tolerance, the long-term benefits appear to be related to inhibition or reversal of the left ventricular dilation that results in a progressive fall in left ventricular ejection fraction. The long-term efficacy of both ACE inhibitors and hydralazine-nitrate in symptomatic heart failure makes the vasodilator combination a rational alternative to an ACE inhibitor and possibly an effective agent for cotherapy with an ACE inhibitor. Trials are needed to test the additive efficacy of this vasodilator combination and to develop other safe and effective drugs that target the progressive remodeling process in heart failure.

References

Rector T, Johnson G, Dunkman W, Daniels G, Farrell L, Henrick A . Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation. 1993; 87(6 Suppl):VI71-7. View

McDonald K, Carlyle P, Matthews J, Hauer K, Elbers T, Hunter D . Early ventricular remodeling after myocardial damage and its attenuation by converting enzyme inhibition. Trans Assoc Am Physicians. 1990; 103:229-35. View

McDonald K, Francis G, Carlyle P, Hauer K, Matthews J, Hunter D . Hemodynamic, left ventricular structural and hormonal changes after discrete myocardial damage in the dog. J Am Coll Cardiol. 1992; 19(2):460-7. DOI: 10.1016/0735-1097(92)90506-i. View

Leier C, Huss P, Magorien R, Unverferth D . Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation. 1983; 67(4):817-22. DOI: 10.1161/01.cir.67.4.817. View

Cintron G, Johnson G, Francis G, Cobb F, Cohn J . Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 1993; 87(6 Suppl):VI17-23. View

Franciosa J, Pierpont G, Cohn J . Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. Ann Intern Med. 1977; 86(4):388-93. DOI: 10.7326/0003-4819-86-4-388. View

Smith R, Johnson G, Ziesche S, Bhat G, Blankenship K, Cohn J . Functional capacity in heart failure. Comparison of methods for assessment and their relation to other indexes of heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 1993; 87(6 Suppl):VI88-93. View

Franciosa J, Nordstrom L, Cohn J . Nitrate therapy for congestive heart failure. JAMA. 1978; 240(5):443-6. View

Franciosa J, Goldsmith S, Cohn J . Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Am J Med. 1980; 69(4):559-66. DOI: 10.1016/0002-9343(80)90468-4. View

10.

Guiha N, Cohn J, Mikulic E, Franciosa J, Limas C . Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med. 1974; 291(12):587-92. DOI: 10.1056/NEJM197409192911201. View

11.

Cohn J, Franciosa J . Vasodilator therapy of cardiac failure: (first of two parts). N Engl J Med. 1977; 297(1):27-31. DOI: 10.1056/NEJM197707072970105. View

12.

Cohn J, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F . A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991; 325(5):303-10. DOI: 10.1056/NEJM199108013250502. View

13.

Massie B, BERK M, Brozena S, Elkayam U, Plehn J, Kukin M . Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET). Circulation. 1993; 88(2):492-501. DOI: 10.1161/01.cir.88.2.492. View

14.

Levine T, Francis G, Goldsmith S, Simon A, Cohn J . Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982; 49(7):1659-66. DOI: 10.1016/0002-9149(82)90243-0. View

15.

Pfeffer M, Braunwald E, Moye L, Basta L, Brown Jr E, Cuddy T . Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327(10):669-77. DOI: 10.1056/NEJM199209033271001. View

16.

Pierpont G, Cohn J, Franciosa J . Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest. 1978; 73(1):8-13. DOI: 10.1378/chest.73.1.8. View

17.

Dunselman P, Kuntze C, van Bruggen A, Hamer J, Scaf A, Wessling H . Efficacy of felodipine in congestive heart failure. Eur Heart J. 1989; 10(4):354-64. DOI: 10.1093/oxfordjournals.eurheartj.a059493. View

18.

Franciosa J, Mikulic E, Cohn J, Jose E, FABIE A . Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation. 1974; 50(5):1020-4. DOI: 10.1161/01.cir.50.5.1020. View

19.

Francis G, Cohn J . Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention. FASEB J. 1990; 4(13):3068-75. DOI: 10.1096/fasebj.4.13.2210153. View

20.

Cohn J, Archibald D, Ziesche S, Franciosa J, Harston W, Tristani F . Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986; 314(24):1547-52. DOI: 10.1056/NEJM198606123142404. View